Cognitive and Memory Function in Patients With Fibromyalgia

NCT ID: NCT00789178

Last Updated: 2008-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-12-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients suffering from Fibromyalgia will be examined for the presence of memory and/or cognitive impairment using specific psychological tests.

Their results will be compared to those with active RA associated with pain and with a normal control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia Cognitive Impairment

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

memory disturbances

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with fibromyalgia

No interventions assigned to this group

patients with active RA

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients suffering from fibromyalgia patients suffering from active RA

Exclusion Criteria

* Patients with depressive disorders Patients treated with SSRI
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assaf-Harofeh Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asaf Harofe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asaf Harofe Medical Center

Zrifin, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Moshe Tishler, MD

Role: CONTACT

Phone: 97289779262

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anat Alon, BA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

154/08

Identifier Type: -

Identifier Source: org_study_id